Physiomics Awarded New Contract by GARDP

AI SummaryClose X

Physiomics plc has secured a new contract with GARDP Foundation to provide expert consultancy support for optimizing the design of an efficacy trial within their Serious Bacterial Infections programme, with work commencing in January 2026 and expected to conclude within three months. This marks the company's second major client in its Biometrics department, which has surpassed initial projections since its launch, representing a significant milestone and a promising contribution to Physiomics' growth objectives, particularly with its expansion into the infectious disease therapeutic area.

Disclaimer*

Companies

Physiomics (PYC)
UK 100

Latest directors dealings